Found: 36
Select item for more details and to access through your institution.
Mind-Body Treatment for International English-Speaking Adults With Neurofibromatosis via Live Videoconferencing: Protocol for a Single-Blind Randomized Controlled Trial.
- Published in:
- Journal of Medical Internet Research, 2018, v. 20, n. 10, p. 138, doi. 10.2196/11008
- By:
- Publication type:
- Article
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2021, v. 152, n. 3, p. 515, doi. 10.1007/s11060-021-03719-5
- By:
- Publication type:
- Article
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trial.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 505, doi. 10.1007/s11060-019-03182-3
- By:
- Publication type:
- Article
Health literacy assessment in adults with neurofibromatosis: electronic and short-form measurement using FCCHL and Health LiTT.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 335, doi. 10.1007/s11060-017-2657-8
- By:
- Publication type:
- Article
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1).
- Published in:
- Acta Neuropathologica, 2024, v. 147, n. 1, p. 1, doi. 10.1007/s00401-024-02724-y
- By:
- Publication type:
- Article
Practical guidance for telemedicine use in neuro-oncology.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 2, p. 91, doi. 10.1093/nop/npac002
- By:
- Publication type:
- Article
Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs.
- Published in:
- Genes, 2020, v. 11, n. 4, p. 1, doi. 10.3390/genes11040387
- By:
- Publication type:
- Article
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 930, doi. 10.1093/oncolo/oyac134
- By:
- Publication type:
- Article
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. e1109, doi. 10.1634/theoncologist.2020-0069
- By:
- Publication type:
- Article
Primary dural lymphomas: Clinical presentation, management, and outcome.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.
- Published in:
- 2019
- By:
- Publication type:
- case study
Reply to L. Lucchino et al. on commentary on "Histologic correlates of "Choroidal Abnormalities" in Neurofibromatosis type 1".
- Published in:
- 2024
- By:
- Publication type:
- Letter
Glioblastoma care in the elderly.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Bevacizumab and glioblastoma: Scientific review, newly reported updates, and ongoing controversies.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 997, doi. 10.1002/cncr.28935
- By:
- Publication type:
- Article
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad041
- By:
- Publication type:
- Article
Vestibular dysfunction in neurofibromatosis type 2-related schwannomatosis.
- Published in:
- Brain Communications, 2023, v. 5, n. 2, p. 1, doi. 10.1093/braincomms/fcad089
- By:
- Publication type:
- Article
Integrating Ataxia Evaluation into Tumor-Induced Hearing Loss Model to Comprehensively Study NF2-Related Schwannomatosis.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 1961, doi. 10.3390/cancers16111961
- By:
- Publication type:
- Article
Understanding barriers to diagnosis in a rare, genetic disease: Delays and errors in diagnosing schwannomatosis.
- Published in:
- American Journal of Medical Genetics. Part A, 2022, v. 188, n. 9, p. 2672, doi. 10.1002/ajmg.a.62860
- By:
- Publication type:
- Article
Genetic testing to gain diagnostic clarity in neurofibromatosis type 2 and schwannomatosis.
- Published in:
- American Journal of Medical Genetics. Part A, 2022, v. 188, n. 8, p. 2413, doi. 10.1002/ajmg.a.62845
- By:
- Publication type:
- Article
First report of factors associated with satisfaction in patients with neurofibromatosis.
- Published in:
- American Journal of Medical Genetics. Part A, 2017, v. 173, n. 3, p. 671, doi. 10.1002/ajmg.a.38079
- By:
- Publication type:
- Article
The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research.
- Published in:
- 2021
- By:
- Publication type:
- letter
Neurologic Immune-Related Adverse Events in Oncology Care.
- Published in:
- JAMA Neurology, 2016, v. 73, n. 8, p. 907, doi. 10.1001/jamaneurol.2016.1564
- By:
- Publication type:
- Article
Controversies in Neuro-Oncology: Best Evidence Medicine for Brain Tumor Surgery.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 9, p. 1195, doi. 10.1001/jamaneurol.2014.1823
- By:
- Publication type:
- Article
Magnetic Resonance Imaging Observations in Primary Central Nervous System Lymphoma.
- Published in:
- JAMA Neurology, 2014, v. 71, n. 7, p. 918, doi. 10.1001/jamaneurol.2014.70
- By:
- Publication type:
- Article
Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 12, p. 2239, doi. 10.1093/neuonc/noad118
- By:
- Publication type:
- Article
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 9, p. 1617, doi. 10.1093/neuonc/noad037
- By:
- Publication type:
- Article
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 331, doi. 10.1093/neuonc/noab262
- By:
- Publication type:
- Article
Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 5, p. 596, doi. 10.1093/neuonc/noy201
- By:
- Publication type:
- Article
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines<sup />.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 4, p. 424, doi. 10.1093/neuonc/noz034
- By:
- Publication type:
- Article
EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 9, p. 1185, doi. 10.1093/neuonc/noy046
- By:
- Publication type:
- Article
Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 531, doi. 10.1093/neuonc/nox245
- By:
- Publication type:
- Article
Hospice utilization in patients with malignant gliomas.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 538, doi. 10.1093/neuonc/nox196
- By:
- Publication type:
- Article
Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 12, p. 1640, doi. 10.1093/neuonc/nox120
- By:
- Publication type:
- Article
Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists.
- Published in:
- 2022
- By:
- Publication type:
- journal article